Insiders · CRDF

CRDF insider transactions

Cardiff Oncology Inc. (CRDF) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CRDF

• 6d
  SEC Form 4 filed by Director Tannenbaum Renee P

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 6d
  SEC Form 4 filed by Director Pace Gary W

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 6d
  SEC Form 4 filed by Director Markin Rodney S

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 6d
  SEC Form 4 filed by Director White Lale

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 6d
  SEC Form 4 filed by Director Armitage James O

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 54d
  SEC Form 4 filed by Chief Operating Officer Aggarwal Ajay

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 54d
  SEC Form 3 filed by new insider Aggarwal Ajay

  3 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 66d
  SEC Form 3 filed by new insider Muntner Joshua B

  3 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 66d
  Amendment: SEC Form 4 filed by Muntner Joshua B

  4/A - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 66d
  SEC Form 4 filed by Smeal Tod

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 66d
  SEC Form 4 filed by Muntner Joshua B

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 80d
  SEC Form 4 filed by Mohindru Mani

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 123d
  SEC Form 4 filed by Chief Accounting Officer Lindsay Brigitte Ute

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 123d
  SEC Form 4 filed by Interim CEO Mohindru Mani

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 132d
  New insider Lindsay Brigitte Ute claimed ownership of 27,431 shares (SEC Form 3)

  3 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 325d
  Director Pace Gary W bought $710,500 worth of shares (290,000 units at $2.45), increasing direct ownership by 26% to 1,330,676 units (SEC Form 4)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 348d
  SEC Form 3 filed by new insider Sidhu Roger

  3 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 356d
  SEC Form 4 filed by Director Tannenbaum Renee P

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 356d
  SEC Form 4 filed by Director Markin Rodney S

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 356d
  SEC Form 4 filed by Director Mohindru Mani

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 359d
  SEC Form 4 filed by Director Armitage James O

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 359d
  SEC Form 4 filed by Director White Lale

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 359d
  SEC Form 4 filed by Director Pace Gary W

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 465d
  SEC Form 4 filed by Chief Medical Officer Kabbinavar Fairooz

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 465d
  SEC Form 4 filed by Chief Financial Officer Levine James E.

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 465d
  SEC Form 4 filed by Chief Scientific Officer Smeal Tod

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 465d
  SEC Form 4 filed by Chief Executive Officer Erlander Mark

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 550d
  Chief Financial Officer Levine James E. bought $36,726 worth of shares (7,716 units at $4.76) (SEC Form 4)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 552d
  Director Tannenbaum Renee P bought $34,224 worth of shares (10,000 units at $3.42), increasing direct ownership by 100% to 20,000 units (SEC Form 4)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 556d
  Director Pace Gary W bought $940,199 worth of shares (361,615 units at $2.60), increasing direct ownership by 50% to 1,047,876 units (SEC Form 4)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 720d
  SEC Form 4 filed by Director White Lale

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 720d
  SEC Form 4 filed by Director Tannenbaum Renee P

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 720d
  SEC Form 4 filed by Director Mohindru Mani

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 720d
  SEC Form 4 filed by Director Pace Gary W

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 720d
  SEC Form 4 filed by Director Armitage James O

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 720d
  SEC Form 4 filed by Director Markin Rodney S

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 836d
  SEC Form 4 filed by Levine James E.

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 836d
  SEC Form 4 filed by Kabbinavar Fairooz

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 836d
  SEC Form 4 filed by Smeal Tod

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 836d
  SEC Form 4 filed by Erlander Mark

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 915d
  Pace Gary W bought $41,100 worth of shares (30,000 units at $1.37), increasing direct ownership by 4% to 697,761 units (SEC Form 4)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1097d
  SEC Form 4 filed by Markin Rodney S

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1097d
  SEC Form 4 filed by Armitage James O

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1097d
  SEC Form 4 filed by White Lale

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1097d
  SEC Form 4 filed by Pace Gary W

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1097d
  SEC Form 4 filed by Mohindru Mani

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1097d
  SEC Form 4 filed by Tannenbaum Renee P

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1193d
  SEC Form 4 filed by Smeal Tod

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1193d
  SEC Form 4 filed by Levine James E.

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1193d
  SEC Form 4 filed by Kelemen Vicki

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1193d
  SEC Form 4 filed by Erlander Mark

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1228d
  SEC Form 3 filed by new insider Kabbinavar Fairooz

  3 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1300d
  SEC Form 4: Erlander Mark bought $14,300 worth of shares (10,000 units at $1.43), increasing direct ownership by 69% to 24,481 units

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1349d
  SEC Form 4: Armitage James O bought $20,233 worth of shares (13,000 units at $1.56)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1370d
  SEC Form 4: White Lale bought $24,525 worth of shares (15,000 units at $1.64)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1371d
  SEC Form 4: Tannenbaum Renee P bought $17,168 worth of shares (10,000 units at $1.72)

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1371d
  SEC Form 4: Pace Gary W bought $256,500 worth of shares (150,000 units at $1.71), increasing direct ownership by 30% to 644,811 units

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1371d
  SEC Form 4: Levine James E. bought $46,710 worth of shares (30,000 units at $1.56), increasing direct ownership by 100% to 60,000 units

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1446d
  SEC Form 4: White Lale exercised 28,858 shares at a strike of $2.60

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)
• 1473d
  SEC Form 4 filed by Brancaccio John P

  4 - Cardiff Oncology, Inc. (0001213037) (Issuer)